A sesterterpenoid derivative alleviates ulcerative colitis through targeting ProRS to suppress the NLRP3 inflammasome.
- DOI
- 10.1007/s11427-025-3367-3
- Published
- 2026 Sep 15
- Container
- Science China. Life sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11427-025-3367-3,
title = {A sesterterpenoid derivative alleviates ulcerative colitis through targeting ProRS to suppress the NLRP3 inflammasome.},
author = {Li M and Zhang H and Fu R and Mao LX and Zheng Y and Wang LL and Liu YC and Zhou TT and Mu RF and Hu H and Liu Y and Li SH},
year = {2026},
journal = {Science China. Life sciences},
doi = {10.1007/s11427-025-3367-3},
url = {https://doi.org/10.1007/s11427-025-3367-3}
}RIS
TY - JOUR TI - A sesterterpenoid derivative alleviates ulcerative colitis through targeting ProRS to suppress the NLRP3 inflammasome. AU - Li M AU - Zhang H AU - Fu R AU - Mao LX AU - Zheng Y AU - Wang LL AU - Liu YC AU - Zhou TT AU - Mu RF AU - Hu H AU - Liu Y AU - Li SH PY - 2026 JO - Science China. Life sciences DO - 10.1007/s11427-025-3367-3 UR - https://doi.org/10.1007/s11427-025-3367-3 ER -
APA
M, L., H, Z., R, F., LX, M., Y, Z., LL, W., YC, L., TT, Z., RF, M., H, H., Y, L., & SH, L. (2026). A sesterterpenoid derivative alleviates ulcerative colitis through targeting ProRS to suppress the NLRP3 inflammasome.. Science China. Life sciences. https://doi.org/10.1007/s11427-025-3367-3
Source records
- pubmed · retrieved 2026-09-25T07:26:31.494Z